Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
JB Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
JB Therapeutics

JB Therapeutics

JB Therapeutics develops new analgesic agents, leading with JBT-101, a potential treatment for osteoarthritis.

HQ
Newton Centre, MA, US
Founded
2009
Overview
Compare
Fundraising
Employees

JB Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative analgesic agents. Their lead compound, JBT-101, is a potent CB1 and CB2 agonist showing efficacy in pain and inflammation models. JBT-101 has completed a Phase II clinical study in chronic refractory neuropathic pain and is being developed as a potential disease-modifying treatment for osteoarthritis.

JB Therapeutics has made significant strides in the biopharmaceutical industry by advancing JBT-101 through critical clinical stages. The company's efforts have the potential to introduce the first new class of analgesic agents in two decades, addressing unmet needs in pain management and osteoarthritis treatment.

JB Therapeutics - Similar Companies

Concentric Analgesics logo

Concentric Analgesics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Bridge Therapeutics logo

Bridge Therapeutics

Centrexion Therapeutics logo

Centrexion Therapeutics

Logical Therapeutics logo

Logical Therapeutics

Neuropathix logo

Neuropathix

neuropathix.com

JDP Therapeutics logo

JDP Therapeutics

JJ Pharma logo

JJ Pharma

Sarentis Therapeutics logo

Sarentis Therapeutics

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

jazzpharma.com

SiteOne Therapeutics logo

SiteOne Therapeutics

Isosceles Pharmaceuticals logo

Isosceles Pharmaceuticals

Amalgent Therapeutics logo

Amalgent Therapeutics

amalgent.com

Aiko Biotechnology logo

Aiko Biotechnology

Sollis Therapeutics logo

Sollis Therapeutics

JB Therapeutics - Quick Facts

Who are JB Therapeutics' competitors?

Companies similar to JB Therapeutics include Concentric Analgesics, NeuroTherapeutics Pharma, Bridge Therapeutics and Centrexion Therapeutics.

When was JB Therapeutics founded?

JB Therapeutics was founded in 2009.

Where is JB Therapeutics' headquarters located?

JB Therapeutics' headquarters is located in Newton Centre, MA, US.

When was JB Therapeutics' last funding round?

JB Therapeutics' most recent funding round was for $25k (USD) in January 2014.

How much has JB Therapeutics raised to-date?

As of Jan 1, 2014, JB Therapeutics has raised a total of $687k (USD).

How many employees does JB Therapeutics have?

JB Therapeutics has 5 employees as of Feb 5, 2024.

JB Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Analgesic Agents
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified